"Designing Growth Strategies is in our DNA"

Brain Tumor Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, and Others), By Indication (Meningioma, Pituitary Tumors, Glioblastoma, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI105025

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Developments- Mergers, Acquisitions and Partnerships
    2. Overview of Regulatory Scenario, By Key Regions
    3. Product Launches By Key Players
    4. Impact of COVID-19 on the Market
    5. Epidemiology of Brain Cancer, Key Region
  5. Global Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    3. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail pharmacy
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Therapy Type
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    3. Market Analysis – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail pharmacy
      3. Others
    5. Market Analysis – By Country
      1. U.S.
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      2. Canada
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
  7. Europe Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Therapy Type
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    3. Market Analysis – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail pharmacy
      3. Others
    5. Market Analysis – By Country/ Sub-region
      1. U.K.
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      2. Germany
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      3. France
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      4. Spain
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      5. Italy
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      6. Scandinavia
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      7. Rest of Europe
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
  8. Asia Pacific Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Therapy Type
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    3. Market Analysis – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail pharmacy
      3. Others
    5. Market Analysis – By Country/ Sub-region
      1. Japan
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      2. China
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      3. India
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      4. Australia
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      5. Southeast Asia
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      6. Rest of Asia Pacific
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
  9. Latin America Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Therapy Type
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    3. Market Analysis – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail pharmacy
      3. Others
    5. Market Analysis – By Country/ Sub-region
      1. Brazil
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      2. Mexico
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      3. Rest of Latin America
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
  10. Middle East & Africa Brain Tumor Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Therapy Type
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    3. Market Analysis – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail pharmacy
      3. Others
    5. Market Analysis – By Country/ Sub-region
      1. GCC Countries
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      2. South Africa
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
      3. Rest of Middle East & Africa
        1. By Indication
          1. Pituitary Tumors
          2. Meningioma
          3. Glioblastoma
          4. Others
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Y-mAbs Therapeutics, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Merck & Co. Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. AstraZeneca
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Bristol-Myers Squibb
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Figure 1:  Global Brain Tumor Drugs Market Revenue Breakdown (USD Billion, %) by Region, 2020 & 2028

Figure 2:  Global Brain Tumor Drugs Market Value Share (%), By Therapy Type, 2020 & 2028

Figure 3:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Targeted Therapy, 2017-2028

Figure 4:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Chemotherapy, 2017-2028

Figure 5:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Immunotherapy, 2017-2028

Figure 6:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Others, 2017-2028

Figure 7:  Global Brain Tumor Drugs Market Value Share (%), by Indication, 2020 & 2028

Figure 8:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Pituitary Tumors, 2017-2028

Figure 9:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Meningioma, 2017-2028

Figure 10:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Glioblastoma, 2017-2028

Figure 11:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Others, 2017-2028

Figure 12:  Global Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2020 & 2028

Figure 13:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Hospital Pharmacy, 2017-2028

Figure 14:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Retail Pharmacy, 2017-2028

Figure 15:  Global Brain Tumor Drugs Market Forecast (USD Billion), by Others, 2017-2028

Figure 16:  Global Brain Tumor Drugs Market Value (USD Billion), by Region, 2020 & 2028

Figure 17:  North America Brain Tumor Drugs Market Value (USD Billion), By Therapy Type, 2020 & 2028

Figure 18:  North America Brain Tumor Drugs Market Value Share (%), By Therapy Type, 2020

Figure 19:  North America Brain Tumor Drugs Market Value (USD Billion), by Indication, 2020 & 2028

Figure 20:  North America Brain Tumor Drugs Market Value Share (%), by Indication, 2020

Figure 21:  North America Brain Tumor Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 22:  North America Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 23:  North America Brain Tumor Drugs Market Value (USD Billion), By Country, 2020 & 2028

Figure 24:  North America Brain Tumor Drugs Market Value Share (%), By Country, 2020

Figure 25:  Europe Brain Tumor Drugs Market Value (USD Billion), By Therapy Type, 2020 & 2028

Figure 26:  Europe Brain Tumor Drugs Market Value Share (%), By Therapy Type, 2020

Figure 27:  Europe Brain Tumor Drugs Market Value (USD Billion), by Indication, 2020 & 2028

Figure 28:  Europe Brain Tumor Drugs Market Value Share (%), by Indication, 2020

Figure 29:  Europe Brain Tumor Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 30:  Europe Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 31:  Europe Brain Tumor Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 32:  Europe Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 33:  Asia Pacific Brain Tumor Drugs Market Value (USD Billion), By Therapy Type, 2020 & 2028

Figure 34:  Asia Pacific Brain Tumor Drugs Market Value Share (%), By Therapy Type, 2020

Figure 35:  Asia Pacific Brain Tumor Drugs Market Value (USD Billion), by Indication, 2020 & 2028

Figure 36:  Asia Pacific Brain Tumor Drugs Market Value Share (%), by Indication, 2020

Figure 37:  Asia Pacific Brain Tumor Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 38:  Asia Pacific Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 39:  Asia Pacific Brain Tumor Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 40:  Asia Pacific Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 41:  Latin America Brain Tumor Drugs Market Value (USD Billion), By Therapy Type, 2020 & 2028

Figure 42:  Latin America Brain Tumor Drugs Market Value Share (%), By Therapy Type, 2020

Figure 43:  Latin America Brain Tumor Drugs Market Value (USD Billion), by Indication, 2020 & 2028

Figure 44:  Latin America Brain Tumor Drugs Market Value Share (%), by Indication, 2020

Figure 45:  Latin America Brain Tumor Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 46:  Latin America Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 47:  Latin America Brain Tumor Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 48:  Latin America Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 49:  Middle East & Africa Brain Tumor Drugs Market Value (USD Billion), By Therapy Type, 2020 & 2028

Figure 50:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), By Therapy Type, 2020

Figure 51:  Middle East & Africa Brain Tumor Drugs Market Value (USD Billion), by Indication, 2020 & 2028

Figure 52:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), by Indication, 2020

Figure 53:  Middle East & Africa Brain Tumor Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 54:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 55:  Middle East & Africa Brain Tumor Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 56:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 57:  Global Brain Tumor Drugs Market Share (%), By Company, 2020

Table 1:  Global Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Therapy Type, 2017–2028

Table 2:  Global Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Indication, 2017–2028

Table 3:  Global Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017–2028

Table 4:  Global Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Region, 2017-2028

Table 5:  North America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Therapy Type, 2017-2028

Table 6:  North America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Indication, 2017-2028

Table 7:  North America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 8:  North America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Country, 2017-2028

Table 9:  Europe Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Therapy Type, 2017-2028

Table 10:  Europe Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Indication, 2017-2028

Table 11:  Europe Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 12:  Europe Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 13:  Asia Pacific Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Therapy Type, 2017-2028

Table 14:  Asia Pacific Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Indication, 2017-2028

Table 15:  Asia Pacific Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 16:  Asia Pacific Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 17:  Latin America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Therapy Type, 2017-2028

Table 18:  Latin America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Indication, 2017-2028

Table 19:  Latin America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 20:  Latin America Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 21:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Therapy Type, 2017-2028

Table 22:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Indication, 2017-2028

Table 23:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 24:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

  • Mar, 2021
  • 2020
  • 2017-2019
  • 135

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X